Untargeted metabolomics identifies unique though benign biochemical changes in patients with pathogenic variants in <i>UROC1</i>.

It is possible, for instance, that there may be significant differences between these two individuals and others with more severe changes like truncating or frameshift variants.

also in 13,097 other papers